UIO-512

N/A

Report date: 2022/01/26 14:47:28

Base Information

Drug NameUIO-512
Drug Alias NameUIO-512
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionImmunomodulatorsApoptosis stimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursOvarian NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUnleash Immuno Oncolytics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursOvarian NeoplasmsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A